Patient Engagement Suite
-
Defending Data Security In The Time Of COVID
4/28/2022
Find out how an increase in COVID-19-related phishing scams forced sponsors and sites to act more diligently in assessing the cybersecurity methods used by their own organizations and partners.
-
Going Global With eConsent
4/20/2022
Scott Askin paints the picture of why Novartis, determined to improve the patient experience, has begun to deploy eConsent, and what they’ve learned along the way.
-
Protocol Amendments And Electronic Consent: Overcoming The Challenges To Reap The Benefits
3/29/2022
Learn about some insights that have been gleaned from experience deploying eConsent on diverse trial types around the world.
-
IRT And Direct-To-Patient Trials
1/12/2022
Want to know more about the growth and expansion for IRT in the decentralized trial space? Witness how IRT is being used to support direct-to-patient delivery in this hybrid trial case study presentation.
-
Climbing The Ladder To Higher Electronic Consent Adoption
11/19/2021
When it comes to gaining the benefits of eConsent in clinical trials, site adoption is the key. Explore the steps up the ladder of eConsent adoption to reach new heights with every study.
-
IRT Design Process For COVID-19 Trials Accelerates Digital Enablement
10/7/2021
Find out what happened when study teams took on challenges pressing biopharmaceutical industry sponsors while working to digitally enable sites and speed up time to first-patient-in for COVID-19 therapeutic and vaccine trials.
-
IRT And eClinical Technology Considerations For Cell And Gene Therapy
8/20/2021
Don't try to fit cell and gene therapy studies – or any kind of study – into pre-defined functionality. The Cenduit IRT and Quantum Interactive™ agile design platforms and reporting tools support clients’ most complex requirements.
-
Navigating The Use Of Controlled Substances In Clinical Trials Using IRT
8/20/2021
Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. Read how this can be challenging for emerging biopharma.
-
Removing The Barriers To eConsent Adoption
8/5/2021
eConsent technology has existed for nearly 20 years in various iterations. Read how sponsors have taken a cautious approach to using eConsent, piloting it on individual studies but refraining from incorporating it across all pipelines in clinical operations.
-
IQVIA Complete Consent
6/17/2021
Engage with this friendly, feature-rich technology platform that's built with powerful, scalable, operational infrastructure that sponsors need to make global implementations successful.